Publicaciones en las que colabora con Carmen Guadalupe Rodríguez González (18)

2019

  1. Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 5, pp. 1357-1362

  2. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2

  3. HTLV testing of solid organ transplant donors

    Clinical Transplantation

  4. HTLV-1 infection in solid organ transplant donors and recipients in Spain

    BMC Infectious Diseases, Vol. 19, Núm. 1

2017

  1. Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088

  2. HIV type 2 epidemic in Spain: Challenges and missing opportunities

    AIDS, Vol. 31, Núm. 10, pp. 1353-1364

  3. Human T-Lymphotropic Virus Infection in Hepatitis C Virus-Antibody Positive Patients in Spain

    AIDS Research and Human Retroviruses, Vol. 33, Núm. 10, pp. 1013-1017

  4. Human T-lymphotropic virus type 1 infection and disease in Spain

    AIDS, Vol. 31, Núm. 12, pp. 1653-1663

2014

  1. Molecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in Spain

    AIDS Research and Human Retroviruses, Vol. 30, Núm. 9, pp. 856-862

2012

  1. Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain

    Virology Journal, Vol. 9, Núm. 1

2011

  1. HTLV infection among foreign pregnant women living in Spain

    Journal of Clinical Virology, Vol. 52, Núm. 2, pp. 119-122

2009

  1. Seroprevalence of HTLV-1/2 infection among native and immigrant pregnant women in Spain

    AIDS Research and Human Retroviruses, Vol. 25, Núm. 6, pp. 551-554

2007

  1. Short communication: Hospital-based surveillance for HTLV-1/2 infections in Spain

    AIDS Research and Human Retroviruses, Vol. 23, Núm. 9, pp. 1075-1077

2005

  1. Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1

    Clinical Infectious Diseases, Vol. 41, Núm. 2, pp. 227-232

  2. Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain

    Clinical Infectious Diseases, Vol. 41, Núm. 9, pp. 1350-1354

2004

  1. HIV-2 and HTLV-I/II infections in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 3, pp. 177-182

2002

  1. Clinical impact of HTLV-1 infection in Spain: Implications for public health and mandatory screening [3]

    Journal of Acquired Immune Deficiency Syndromes

1996

  1. Epidemiology of HIV-2 infection in Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 15, Núm. 5, pp. 383-388